By www.reliablemarketforecast.com
Global Anti-Parkinson Drugs Market Size, Status And Forecast 2024-2031 Story
108
$ 3900
Anti-Parkinson Drugs Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
AbbVie Mylan Laboratories Valeant Pharmaceuticals Novartis GlaxoSmithKline Zambon Pharmaceuticals Pfizer, Inc. Hoffmann-La Roche Merck & Co. Orion Pharma UCB Teva Pharmaceutical Industries Ltd. Vertical Pharmaceuticals, LLC ACADIA Pharmaceuticals Inc.